LongCovid
This recent study showed that myricetin (3,5,7-trihydroxy-2-(3,4,5-tri hydroxyphenyl)-4-benzopyrone), a common flavonol extracted from many natural plants and Chinese herb medicines, is able to inhibit binding between the receptor binding domain (RBD) of the SARS-CoV-2 protein and angiotensin-converting enzyme 2 (ACE2), demonstrating its potential as a viral-entry facilitator blocker. Furthermore, myricetin could also significantly inhibit SASR-CoV-2 replication in Vero E6 cells.
Study Highlights: – Reduced O2 pulse peak % predicted (impaired oxygen extraction) may be a mechanism of chronic fatigue and exercise intolerance in Long COVID. – The study identified…
The San Diego Union-Tribune has recently published an editorial on the new Long COVID study by Dr. Ziyad Al-Alyand (Nature Medicine Journal). „The perception that the pandemic is…
A new perspective article published by Frontiers in Medicine proposes a multipronged clinical trial platform approach that addresses the complexity and heterogeneity of Post-COVID and ME/CFS, enabling to test numerous drugs in…
„Three years into the COVID-19 pandemic, with millions of people around the world suffering from long-term complications of the virus, there is still no proven way to treat or prevent…